Neuphoria Therapeutics Inc.
NEUP
Rankning i aktier
#29112
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Aktiekurs
$3.92
Senast synkroniserad: 2026-07-31
Marknadsvärde
$21.16M
Förändring (1 dag)
-0.13%
Förändring (1 år)
60,767.52%
Land
US
Handel Neuphoria Therapeutics Inc. (NEUP)
Kategori
Healthcare
Aktiekurshistorik för Neuphoria Therapeutics Inc. (NEUP)
Högsta slutkurs: $0.01 den 2023-08-01
Lägsta slutkurs: $0.56 den 1999-12-01
Lägsta slutkurs: $0.56 den 1999-12-01
Aktiekurshistorik för Neuphoria Therapeutics Inc. från 1999 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2023 | -78.35% |
| 2022 | -97.66% |
| 2021 | 1,363.12% |
| 2020 | 63.69% |
| 2019 | -30.83% |
| 2018 | -71.66% |
| 2017 | 18.70% |
| 2016 | -12.16% |
| 2015 | -19.29% |
| 2014 | -47.97% |
| 2013 | 95.06% |
| 2012 | -36.40% |
| 2011 | -90.46% |
| 2010 | 1,655.11% |
| 2009 | 133.43% |
| 2008 | -61.74% |
| 2007 | 121.34% |
| 2006 | 1.97% |
| 2005 | -16.73% |
| 2004 | -11.05% |
| 2003 | -22.47% |
| 2002 | -28.01% |
| 2001 | -20.19% |
| 2000 | -11.88% |
| 1999 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $536.74 | 25.87% |
US
|
|
| $227.23 | 746.28% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $881.75 | 8.30% |
NL
|
